The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2023

Filed:

Dec. 08, 2017
Applicants:

Massachusetts Institute of Technology, Cambridge, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Carlo Giovanni Traverso, Newton, MA (US);

Ashok Kakkar, Pointe-Claire, CA;

Joshua Korzenik, Waban, MA (US);

Robert S. Langer, Newton, MA (US);

Sufeng Zhang, Cambridge, MA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/50 (2006.01); C08F 220/56 (2006.01); A61K 47/34 (2017.01); A61K 9/51 (2006.01); A61K 38/19 (2006.01); A61K 31/58 (2006.01); A61K 47/54 (2017.01); A61K 47/58 (2017.01); A61K 9/00 (2006.01); C08F 220/54 (2006.01); C08F 224/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5052 (2013.01); A61K 9/0024 (2013.01); A61K 9/5026 (2013.01); A61K 9/5036 (2013.01); A61K 9/5169 (2013.01); A61K 31/58 (2013.01); A61K 38/193 (2013.01); A61K 47/34 (2013.01); A61K 47/54 (2017.08); A61K 47/58 (2017.08); C08F 220/54 (2013.01); C08F 220/56 (2013.01); C08F 224/00 (2013.01);
Abstract

Compositions, articles, and methods for targeted drug delivery, such as thermoresponsive hydrogel polymers, are generally provided. In one aspect, the compositions and articles comprise a thermoresponsive hydrogel polymer comprising a releasable therapeutic agent. In some cases, the compositions described herein have advantageous combinations of properties including mechanical strength, biocompatibility, tunable charge densities, thermal responsiveness, drug loading, and/or configurations for targeted drug delivery. In one embodiment, the composition comprises a solution comprising a thermoresponsive polymer including one or more ligands attached to the polymer, wherein the solution is configured to undergo a sol-to-gel transition under physiological conditions. In another embodiment, the composition comprises a plurality of nanoparticles e.g., associated with the thermoresponsive polymer. In yet another embodiment, the composition comprises a therapeutic agent e.g., associated with the nanoparticles and/or thermoresponsive polymer.


Find Patent Forward Citations

Loading…